Phillip G. Febbo, Chief Scientific and Medical Officer at Veracyte Inc. ($VCYT), made two open market sales of company shares in the last 365 days, totaling $786,138. His most recent sale was on March 2, 2026. These transactions rank 5,454th in sales value among 11,678 insiders, well below the average of $8.6 million and 6.4 sales per insider. Febbo has recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 6578 | $0.00 | 153,527.0000 | 79,946,386 | 4.48% | 0.01% |
| March 6, 2026 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 29603 | $0.00 | 146,949.0000 | 79,946,386 | 25.23% | 0.04% |
| March 2, 2026 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | S | Common Stock | 13425 | $36.16 | 117,346.0000 | 79,946,386 | 10.27% | 0.02% |
| March 2, 2026 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 6035 | $36.01 | 130,771.0000 | 79,946,386 | 4.41% | 0.01% |
| Feb. 26, 2026 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 71806 | $0.00 | 161,292.0000 | 79,946,386 | 80.24% | 0.09% |
| Feb. 26, 2026 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 24486 | $38.75 | 136,806.0000 | 79,946,386 | 15.18% | 0.03% |
| Dec. 2, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 2955 | $46.16 | 89,486.0000 | 79,946,386 | 3.20% | 0.00% |
| Oct. 6, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | S | Common Stock | 8349 | $36.02 | 92,441.0000 | 79,946,386 | 8.28% | 0.01% |
| Sept. 2, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 2955 | $30.11 | 100,790.0000 | 78,163,217 | 2.85% | 0.00% |
| June 2, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 2955 | $26.74 | 103,745.0000 | 78,163,217 | 2.77% | 0.00% |
| March 6, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 24160 | $0.00 | 106,700.0000 | 78,163,217 | 29.27% | 0.03% |
| March 4, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | S | Common Stock | 3570 | $33.95 | 82,540.0000 | 78,163,217 | 4.15% | 0.00% |
| March 4, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | S | Common Stock | 4467 | $32.86 | 86,110.0000 | 78,163,217 | 4.93% | 0.01% |
| March 2, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 6754 | $34.76 | 90,577.0000 | 78,163,217 | 6.94% | 0.01% |
| Feb. 27, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 15672 | $33.84 | 97,331.0000 | 78,163,217 | 13.87% | 0.02% |
| Feb. 27, 2025 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 30589 | $0.00 | 113,003.0000 | 78,163,217 | 37.12% | 0.04% |
| Dec. 4, 2024 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | S | Common Stock | 3934 | $44.09 | 82,414.0000 | 78,465,000 | 4.56% | 0.01% |
| Dec. 2, 2024 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | F | Common Stock | 6738 | $44.12 | 86,348.0000 | 78,465,000 | 7.24% | 0.01% |
| March 6, 2024 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 39904 | $0.00 | 93,086.0000 | 72,644,487 | 75.03% | 0.05% |
| Oct. 2, 2023 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Common Stock | 53182 | $0.00 | 53,182.0000 | 71,549,204 | 9999.99% | 0.07% |
| Oct. 2, 2023 | VERACYTE, INC. | $VCYT | Febbo Phillip G. | Chief Scientific & Med Officer | A | Stock Option (right to buy) | 85858 | $0.00 | 85,858.0000 | 71,549,204 | 9999.99% | 0.12% |